Indiana University
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, Indiana University sits in the top decile of US sponsors by registered trial count (#38 of 15,742 sponsors by registered trial count).
Indiana University: 890 sponsored US clinical trials, 156 recruiting.
Indiana University sponsors 890 registered US clinical trials on ClinicalTrials.gov, 156 of them currently recruiting, and 561 completed. 104 of these trials are in Phase 3-4 (later-stage) and 126 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Alzheimer Disease, with 11 trials.
Top-decile sponsor footprint
Indiana University ranks in the top decile of sponsors by registered trial count (#38 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
561 of 688 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (81.5%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
890 total, page 5 of 18
ImmuNe ParameTERs to Predict Immunotherapy REsponse and Toxicity (INTERPRET)
NCT06900296
Testing the Effects of Music on Short and Long Term Psychological Outcomes and Step Counts in Children
NCT07358871
3D Scanning as an Advanced Tool for Identifying Tooth Lesions in Children
NCT06829550
Innovative Cognitive Impairment Case Finding and Engagement for Diverse Participation in Alzheimer's Disease Care, Treatment, And Research
NCT07016178
[18F]-AraG PET Imaging in LA HNSCC
NCT07168785
Establishing Baseline Sysmex UF-5000 Flow Cytometer Results in Healthy Men
NCT06951009
Hoosier Sport Re-Social: A Biobehavioral Intervention in Rural Indiana
NCT06556719
Safety of Stopping Pancreatic Enzyme Replacement Therapy in Children With Improved Pancreatic Function After Highly Effective Modulator Therapy
NCT07632768
Evaluation of the Efficacy and Safety of a Loop Stretchable Dental Floss
NCT06515483
Uncovering the Acute Neurobiological Significance of Emerging Sexual Behaviors
NCT06602362
Hoosier Sport: Refining and Implementing a Sustainable Campus-Community Partnership in Rural Indiana
NCT06602596
CYTALUX™for the Intraoperative Imaging of Prostate Cancer
NCT06434909
Satisfaction With eMotion in a Diverse Group of Women
NCT06404866
Developing a Childhood Asthma Risk Passive Digital Marker
NCT05826561
Inspiratory Muscle Training in Postmenopausal Women
NCT06459674
Assessment of the Safety and Efficacy of Weighted Wearable Blankets in Healthy Infants During Sleep
NCT06422364
Aging Brain Care Virtual Program
NCT06245499
Hoosier Sport: Developing and Implementing a Sustainable Campus-Community Partnership in Rural Indiana
NCT06280859
Organoid Model Predictive of Response to Immunotherapies
NCT06084676
Behavioral Activation in Depressed Online Workers
NCT06181825
Combination of Buffered Anesthetic to Treat Mandibular Molars
NCT06047366
Suction Cervical Stabilizer Compared to Standard Tenaculum for Intrauterine Procedures
NCT06193590
Acute Clinical Outcomes of Hemorrhagic Myocardial Infarction
NCT06110351
In Situ Comparison of the Remineralization Potential of Optimized Fluoride Dentifrice With Control Fluoride Dentifrice
NCT06010732
Pilot Study to Determine Pro-Inflammatory Cytokine Kinetics During Immune Checkpoint Inhibitor Therapy
NCT05707286
The Effects of Environmental Distractions on SCAT6 Outcomes
NCT05886400
Enhancing Prospective Thinking in Early Recovery (NERF)
NCT06283446
Patient Priorities Care Among Persons Living With Mild Cognitive Impairment and Dementia
NCT06001775
Intraperitoneal Bupivacaine for Pelvic Organ Prolapse
NCT06120530
Biventricular Versus Right Ventricular Pacing
NCT06298669
MIrabegron and Physiological Function in Cold Environments
NCT05990387
The Impact of Beef on Muscle Fatigue in Older Adults
NCT05860088
VisionApp - Refraction and Presbyopia
NCT07570602
Contraception Navigator Program
NCT05691270
Equity Using Interventions for Pain and Depression - Pilot Study
NCT05695209
Study of a Rapid Triadic Communication Intention Elicitation Intervention to Improve Supportive Oncology Care Delivery
NCT05995860
Frontal and Parietal Contributions to Proprioception and Motor Skill Learning
NCT05739994
Macrowire for IntracraNial Thrombectomy
NCT06148675
Effect of Virtual Reality-based Training on Balance and Walking in Youth With Autism Spectrum Disorder
NCT06023563
Discerning the Impact of ctDNA Detection on Patient Decision Making in Early Stage Breast Cancer: a Conjoint Analysis
NCT05730010
Enhancing Prospective Thinking in Early Recovery (PARK)
NCT05908097
DIGITAL Biomarker: Blood Based Biomarkers in the Primary Care Setting for Alzheimer's Disease
NCT05844488
Digital Weight Bearing Shape Capture Socket Technology
NCT05749952
Evaluate Pharmacokinetics and Safety of Slow Release DHEA
NCT05623059
Building Emotional Self-Awareness Teletherapy (BEST)
NCT05623046
A Mindfulness-based Intervention for Adolescents With Prediabetes or Type 2 Diabetes
NCT07270900
Acute Effects of Beetroot Juice on Locomotor Economy and Capacity in Chronic Stroke
NCT05720013
Comparing Brief Relaxation Period to Virtual Reality Period in Reducing Dental Anxiety Prior to Root Canal Treatment
NCT05720897
Structure and Function of Retinal Disease
NCT05643157
Drug-gene-nutraceutical Interactions of Cannabidiol and Tacrolimus
NCT05490511
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 56 |
| Phase 2 | 70 |
| Phase 3 | 28 |
| Phase 4 | 76 |
Therapeutic Areas
What is open in the Indiana University pipeline
156 recruiting of 890 indexed (18% open); 561 completed (63%).
Phase mix: 104 late (III/IV) vs 126 early (I/II) (balanced across stages).
Top condition: Alzheimer Disease (11 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Indiana University: open-pipeline peers nationwide
Peers matched on 890 registered trials and 18% open enrollment, not the therapeutic-area sidebar.
Indiana University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 890 trials (± recruiting share)
- University of California, Los Angeles · 897 trials · 18% recruiting
- Hoffmann-La Roche · 909 trials · 8% recruiting
- Brigham and Women's Hospital · 937 trials · 15% recruiting
- University of Texas Southwestern Medical Center · 837 trials · 19% recruiting
Sponsors near 18% open enrollment (± trial volume)
- Edwards Lifesciences · 18% recruiting · 57 trials
- University of South Florida · 17% recruiting · 252 trials
- VA Office of Research and Development · 17% recruiting · 1,668 trials
- ConvaTec · 18% recruiting · 17 trials
Related
What to do with this Indiana University page
890 registered trials is a research-attention snapshot, not an endorsement of Indiana University or any single study.
- 156 of Indiana University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Alzheimer Disease is the condition Indiana University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Alzheimer Disease trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Indiana University pipeline card: 890 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.